Effects of experimental diabetes on endothelin-induced ventricular arrhythmias in dogs

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Pósa, Ildikó ^a   Horkay, Ferenc ^a   Seres, Leila ^a   Skoumal, Réka ^a   Kováts, Timea ^a   Balogh, Éva ^a   De Châtel, Rudolf ^b,c   Tóth, Miklós ^a,b,c   Kocsis, Erzsébet ^a  

^a National Institute of Cardiology Budapest   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Arrhythmia; Diabetes; Dog; Intracoronary; Local hyperglycaemia

Indexed keywords

ALLOXAN; ENDOTHELIN; ENDOTHELIN 1; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DOG; ELECTROCARDIOGRAM; EXPERIMENT; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HEMODYNAMIC PARAMETERS; HYPERGLYCEMIA; INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEASUREMENT; METABOLISM; NONHUMAN; PARAMETER; PRIORITY JOURNAL; QT PROLONGATION; TIME;

ANIMALS; BLOOD PRESSURE; CORONARY CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; DOGS; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; GLUCOSE; HEART RATE; HEMODYNAMICS; INFUSIONS, PARENTERAL; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 11144323267     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166298.10443.45     Document Type: Conference Paper

References (13)

1. Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens. 1998;16:1081-1098.
2. Toth M, Solti F, Merkely B, et al. Ventricular tachycardias induced by intracoronary administration of endothelin-1 in dogs. J Cardiovasc Pharmacol. 1995; 26(Suppl 3):S153-S155.
3. Szokodi I, Horkay F, Merkely B, et al. Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs. Cardiovasc Res. 1998;38:356-364.
4. Duru F, Barton M, Luscher TF, et al. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc Res. 2001;49:272-280.
5. Szabo T, Geller L, Merkely B, et al. Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect? Life Sci. 2000;66:2527-2541.
6. Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med. 2003;163:33-40.
7. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis. 1985;27:255-270.
8. Luscher TF, Creager MA, Beckman JA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation. 2003;108:1655-1661.
9. Creager MA, Luscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527-1532.
10. Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrin Metab. 1995;80:829-835.
11. Wu SQ, Hopfner RL, McNeill JR, et al. Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res. 2000;45:994-1000.
12. Cardillo C, Campia U, Bryant MB, et al. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 2002;106:1783-1787.
13. Morise T, Takeuchi Y, Kawano M, et al. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM. Diabetes Care. 1995;18:87-89.